Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 20, 2025Open Access

A Multi-Antigen Broad-Spectrum Coronavirus Vaccine Induces Potent and Durable Cross- Protection Against Infection and Disease Caused by Multiple SARS-CoV-2 Variants

View Full Paper
Ask AI
Bookmark
Share

Authors

SPSwayam PrakashNDNisha R. DhanushkodiAQAfshana Quadiri

Discussion

Loading...

Member takes

Overview

Research demonstrates potent immunity against multiple SARS-CoV-2 variants, suggesting an effective next-generation vaccine.

Key Points

  • The new coronavirus vaccine induces strong, long-lasting protection against various SARS-CoV-2 variants, improving on existing vaccines.
  • Key immunological responses include increased numbers of specific T cells that effectively combat SARS-CoV-2 and its variants.
  • Using a model with golden Syrian hamsters, the vaccine notably reduces lung pathology and viral load following exposure to VOCs.
  • These findings highlight the potential for this multi-antigen vaccine to improve current vaccination strategies and address future variants.

Cite This Study

Prakash et al. (2025) studied this question.

synapsesocial.com/papers/68af4eaead7bf08b1ead714bhttps://doi.org/10.21203/rs.3.rs-7208748/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Multi-antigen coronavirus vaccine induces potent and durable cross-protection against multiple SARS-CoV-2 variants2026
  2. 2A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model2024 · 9 citations
  3. 3Conserved CD8 T cell vaccines without B cell epitopes drive robust protection against SARS-CoV-2 that is enhanced by intranasal boost2025
  4. 4MultiTEP-Based Vaccines Targeting SARS-CoV-2 Spike Protein IgG Epitopes Elicit Robust Binding Antibody Titers with Limited Virus-Neutralizing Activity2024 · 2 citations
  5. 5Design and immunogenicity evaluation of pan-recombinant vaccines based on the consensus sequence of severe acute respiratory syndrome coronavirus-2 spike protein2026